Literature DB >> 29094789

Relationship between symptoms and quality of life in fecal incontinence.

K Bedard1, S Heymen2, O S Palsson3, A E Bharucha4, W E Whitehead3.   

Abstract

BACKGROUND: Most measures of fecal incontinence (FI) severity assess the frequency of solid and liquid FI, but may incorporate other features. We compared two scales-the Fecal Incontinence Severity Score (FISS) and Fecal Incontinence Severity Index (FISI)-to determine which questionnaire and which individual questions predict FI Quality of Life (FIQOL).
METHODS: A national sample of American adults completed a health questionnaire, and 234 with monthly FI were selected. Participants completed assessments of FI severity, FIQOL, and somatization. Stepwise linear regression models evaluated whether FISS and FISI total scores, or individual items on the FISS and FISI predicted FIQOL after adjusting for gender, age, income, and somatization (Brief Symptom Inventory-18). KEY
RESULTS: Reliable responses were provided by 186. Age was 49 years, and 52% were women. The mean FISS score was 8.4 (95% confidence interval [CI] 8.0-8.9, 13 questions) and mean FISI was 29.9 (95% CI 27.4-32.4, 62 questions), indicating moderate FI severity. The mean FIQOL was 2.6 (95% CI 2.4-2.7, 5 questions). Lower income, greater somatization, and total FISS and FISI scores explained 69% of FIQOL; and total FISS and FISI scores were independent predictors. On the FISS, frequency, amount, and urgency to defecate were independently associated with FIQOL. After adding somatization, all but amount remained significant. For the FISI scale, solid and liquid FI and gas were significant predictors, but adjusting for somatization excluded solid FI. CONCLUSIONS AND INFERENCES: Five variables independently explained FIQOL: overall frequency of FI, frequency of liquid and gas leakage, urgency, and somatization.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  fecal incontinence; quality of life; somatization/comorbidity

Mesh:

Year:  2017        PMID: 29094789      PMCID: PMC5869683          DOI: 10.1111/nmo.13241

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  18 in total

1.  Fecal Incontinence Quality of Life Scale: quality of life instrument for patients with fecal incontinence.

Authors:  T H Rockwood; J M Church; J W Fleshman; R L Kane; C Mavrantonis; A G Thorson; S D Wexner; D Bliss; A C Lowry
Journal:  Dis Colon Rectum       Date:  2000-01       Impact factor: 4.585

2.  Symptoms and quality of life in community women with fecal incontinence.

Authors:  Adil E Bharucha; Alan R Zinsmeister; G Richard Locke; Cathy Schleck; Kimberly McKeon; L Joseph Melton
Journal:  Clin Gastroenterol Hepatol       Date:  2006-08       Impact factor: 11.382

3.  Selecting an outcome measure for evaluating treatment in fecal incontinence.

Authors:  Marije Deutekom; Maaike P Terra; Annette C Dobben; Marcel G W Dijkgraaf; Richelle J F Felt-Bersma; Jaap Stoker; Patrick M M Bossuyt
Journal:  Dis Colon Rectum       Date:  2005-12       Impact factor: 4.585

4.  Prospective comparison of faecal incontinence grading systems.

Authors:  C J Vaizey; E Carapeti; J A Cahill; M A Kamm
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

5.  Patient and surgeon ranking of the severity of symptoms associated with fecal incontinence: the fecal incontinence severity index.

Authors:  T H Rockwood; J M Church; J W Fleshman; R L Kane; C Mavrantonis; A G Thorson; S D Wexner; D Bliss; A C Lowry
Journal:  Dis Colon Rectum       Date:  1999-12       Impact factor: 4.585

6.  Symptom outcomes important to women with anal incontinence: a conceptual framework.

Authors:  Vivian W Sung; Rebecca G Rogers; Carla M Bann; Lily Arya; Matthew D Barber; Jerry Lowder; Emily S Lukacz; Alayne Markland; Nazema Siddiqui; Amanda Wilmot; Susan F Meikle
Journal:  Obstet Gynecol       Date:  2014-05       Impact factor: 7.661

7.  A new questionnaire for constipation and faecal incontinence.

Authors:  A E Bharucha; G R Locke; B M Seide; A R Zinsmeister
Journal:  Aliment Pharmacol Ther       Date:  2004-08-01       Impact factor: 8.171

Review 8.  Somatic comorbidities of irritable bowel syndrome: a systematic analysis.

Authors:  Andrea Riedl; Marco Schmidtmann; Andreas Stengel; Miriam Goebel; Anna-Sophia Wisser; Burghard F Klapp; Hubert Mönnikes
Journal:  J Psychosom Res       Date:  2008-04-28       Impact factor: 3.006

9.  Fecal incontinence in US adults: epidemiology and risk factors.

Authors:  William E Whitehead; Lori Borrud; Patricia S Goode; Susan Meikle; Elizabeth R Mueller; Ashok Tuteja; Alison Weidner; Milena Weinstein; Wen Ye
Journal:  Gastroenterology       Date:  2009-05-04       Impact factor: 22.682

10.  The impact of psychiatric and extraintestinal comorbidity on quality of life and bowel symptom burden in functional GI disorders.

Authors:  J Vu; V Kushnir; B Cassell; C P Gyawali; G S Sayuk
Journal:  Neurogastroenterol Motil       Date:  2014-07-29       Impact factor: 3.598

View more
  3 in total

Review 1.  Faecal incontinence in adults.

Authors:  Adil E Bharucha; Charles H Knowles; Isabelle Mack; Allison Malcolm; Nicholas Oblizajek; Satish Rao; S Mark Scott; Andrea Shin; Paul Enck
Journal:  Nat Rev Dis Primers       Date:  2022-08-10       Impact factor: 65.038

2.  Comparative effectiveness of biofeedback and injectable bulking agents for treatment of fecal incontinence: Design and methods.

Authors:  Adil E Bharucha; Marie G Gantz; Satish S Rao; Ann C Lowry; Heidi Chua; Tennekoon Karunaratne; Jennifer Wu; Frank A Hamilton; William E Whitehead
Journal:  Contemp Clin Trials       Date:  2021-06-15       Impact factor: 2.261

3.  Translumbosacral Neuromodulation Therapy for Fecal Incontinence: A Randomized Frequency Response Trial.

Authors:  Satish S C Rao; Xuelian Xiang; Amol Sharma; Tanisa Patcharatrakul; Yun Yan; Rachael Parr; Deepak Ayyala; Shaheen Hamdy
Journal:  Am J Gastroenterol       Date:  2021-01-01       Impact factor: 12.045

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.